Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Barbara Pro; Ranjana Advani; Pauline Brice; Nancy L Bartlett; Joseph D. Rosenblatt; Timothy Illidge; Jeffrey Matous; Radhakrishnan Ramchandren; Michelle Fanale; Joseph M. Connors; Keenan Fenton; Dirk Huebner; Juan Pinelli; Dana A Kennedy; Andrei Shustov

doi:10.1182/BLOOD-2017-05-780049

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Barbara Pro
, Ranjana Advani
, Pauline Brice
, Nancy L Bartlett
, Joseph D. Rosenblatt
, Timothy Illidge
, Jeffrey Matous
, Radhakrishnan Ramchandren
, Michelle Fanale
, Joseph M. Connors
, Keenan Fenton
, Dirk Huebner
, Juan Pinelli
, Dana A Kennedy
, Andrei Shustov

Robert H. Lurie Comprehensive Cancer Center, Chicago, IL;
Stanford University
Hemato-oncology Department, Hospital Saint-Louis, Paris, France;
Washington University in St. Louis
University of Miami
National Health Service
Colorado Blood and Cancer Institute, Denver, CO;
Karmanos Cancer Institute, Detroit, MI;
University of Texas MD Anderson Cancer Center
BC Cancer Agency
Seattle Genetics
Millennium Pharmaceuticals
University of Washington

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	130
Issue number	25
DOIs	https://doi.org/10.1182/BLOOD-2017-05-780049
State	Published - Dec 21 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Surgery
Survival Analysis
Internal Medicine

Access to Document

10.1182/BLOOD-2017-05-780049License: Unspecified

Cite this

Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J., Kennedy, D. A., & Shustov, A. (2017). Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood, 130(25). https://doi.org/10.1182/BLOOD-2017-05-780049

Pro, B, Advani, R, Brice, P, Bartlett, NL, Rosenblatt, JD, Illidge, T, Matous, J, Ramchandren, R, Fanale, M, Connors, JM, Fenton, K, Huebner, D, Pinelli, J, Kennedy, DA & Shustov, A 2017, 'Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.', Blood, vol. 130, no. 25. https://doi.org/10.1182/BLOOD-2017-05-780049

@article{3cbd2316eeed43ae91f20bd043e87d98,

title = "Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.",

author = "Barbara Pro and Ranjana Advani and Pauline Brice and Bartlett, \{Nancy L\} and Rosenblatt, \{Joseph D.\} and Timothy Illidge and Jeffrey Matous and Radhakrishnan Ramchandren and Michelle Fanale and Connors, \{Joseph M.\} and Keenan Fenton and Dirk Huebner and Juan Pinelli and Kennedy, \{Dana A\} and Andrei Shustov",

note = "Barbara Pro, 1 Ranjana Advani, 2 Pauline Brice, 3 Nancy L. Bartlett, 4 Joseph D. Rosenblatt, 5 Tim Illidge, 6 Jeffrey Matous, 7 Radhakrishnan Ramchandren, 8 Michelle Fanale, 9 Joseph M. Connors, 10 Keenan Fenton, 11 Dirk Huebner, 12 Juan M. Pinelli, 11 Dana A.",

year = "2017",

month = dec,

day = "21",

doi = "10.1182/BLOOD-2017-05-780049",

language = "American English",

volume = "130",

journal = "Blood",

publisher = "American Society of Hematology",

number = "25",

}

TY - JOUR

T1 - Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

AU - Pro, Barbara

AU - Advani, Ranjana

AU - Brice, Pauline

AU - Bartlett, Nancy L

AU - Rosenblatt, Joseph D.

AU - Illidge, Timothy

AU - Matous, Jeffrey

AU - Ramchandren, Radhakrishnan

AU - Fanale, Michelle

AU - Connors, Joseph M.

AU - Fenton, Keenan

AU - Huebner, Dirk

AU - Pinelli, Juan

AU - Kennedy, Dana A

AU - Shustov, Andrei

N1 - Barbara Pro, 1 Ranjana Advani, 2 Pauline Brice, 3 Nancy L. Bartlett, 4 Joseph D. Rosenblatt, 5 Tim Illidge, 6 Jeffrey Matous, 7 Radhakrishnan Ramchandren, 8 Michelle Fanale, 9 Joseph M. Connors, 10 Keenan Fenton, 11 Dirk Huebner, 12 Juan M. Pinelli, 11 Dana A.

PY - 2017/12/21

Y1 - 2017/12/21

UR - http://europepmc.org/articles/PMC5746164

U2 - 10.1182/BLOOD-2017-05-780049

DO - 10.1182/BLOOD-2017-05-780049

M3 - Article

VL - 130

JO - Blood

JF - Blood

IS - 25

ER -

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Disciplines

Access to Document

Other files and links

Cite this